Median serum sST2 (21.8 vs 19.1 ng/mL, p < 0.0001) and hs-cTnI (6.1 vs 5.7 ng/L, p = 0.0077) levels were higher in T2DM patients compared to CTR, while no significant difference was observed for NT-proBNP (62 vs. 69 ng/L, p = 0.453) (Fig. 1A). This evidence concerns the gene TNNI3 and type 2 diabetes mellitus.